$359.41
-16.69-4.44%
Last update: Oct 30, 7:07 PM
Charles River Laboratories International Inc
CRLNYSE
Charles River (CRL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Charles River (CRL) last issued guidance on September 24, 2026 for fiscal year 2026. The company guided earnings per share in the range of $11.45 - $11.45, compared to a consensus EPS estimate of $11.33. Charles River also guided revenue in the range of $3.92B - $3.92B for the period.
Compared to prior guidance, Charles River raised its EPS outlook from a previous range of $11.15 - $11.45. On the revenue side, the company maintained its revenue forecast from a prior range of $3.87B - $3.92B.
Charles River has issued 19 guidance updates between November 2, 2022 and September 24, 2026. During this period, the company raised its outlook 9 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $2.73 | $1.95 | $2.34 | $2.33 |
| Actual | $3.02 | $2.06 | $2.39 | $2.43 |
| Surprise | +10.6% | +5.64% | +2.14% | +4.29% |
| Revenue | ||||
| Estimate | $973.2M | $976.2M | $986.6M | $988.3M |
| Actual | $1.00B | $995.8M | $994.2M | $1.00B |
| Surprise | +3.17% | +2.01% | +0.78% | +1.67% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $2.97 | $3.32 | $2.66 | $3.28 |
| Revenue | ||||
| Consensus | $959.6M | $956.5M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $3.02 | $2.73 | 10.6 % |
| Q1 | May 7, 2026 | $2.06 | $1.95 | 5.64 % |
| Q4 | Feb 18, 2026 | $2.39 | $2.34 | 2.14 % |
| Q3 | Nov 5, 2025 | $2.43 | $2.33 | 4.29 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $1.00B | $973.18M | 3.17 % |
| Q1 | May 7, 2026 | $995.83M | $976.16M | 2.01 % |
| Q4 | Feb 18, 2026 | $994.23M | $986.56M | 0.78 % |
| Q3 | Nov 5, 2025 | $1.00B | $988.30M | 1.67 % |
